Full Text View
Tabular View
No Study Results Posted
Related Studies
Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation
This study is ongoing, but not recruiting participants.
Study NCT00042744   Information provided by National Cancer Institute (NCI)
First Received: August 5, 2002   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft Versus Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
visilizumab
Sponsors listed in this trial
PDL BioPharma, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services